Overview
- 8 inspections across 7 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-11-21.
At a glance
Inspections
8
Sites
7
Observations
0
Career since
May 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 21 Nov 2025 | Biologics | |
| Axogen Corp | 29 Apr 2025 | Biologics | On file |
| Neurotech Pharmaceuticals, Inc. | 26 Jul 2024 | Biologics | On file |
| Biotest Ag | 15 Dec 2023 | Biologics | On file |
| GenIbet Biopharmaceuticals | 31 Jan 2023 | Biologics | On file |
Sites inspected
Merck Sharp & Dohme LLCElkton, United States1 insp.
Axogen CorpVandalia, United States1 insp.
Neurotech Pharmaceuticals, Inc.Cumberland, United States1 insp.
Biotest AgDreieich, Germany1 insp.
GenIbet BiopharmaceuticalsOeiras, Portugal1 insp.
Co-investigators
Investigators who share inspections with this person.
Kathleen R Jones3 shared
Neetu Dahiya2 shared
Lori P Peters2 shared
Wen J Seeto1 shared
Jin S Hong1 shared
Kyung E Sung1 shared
Carolina Panico1 shared
Alyssa N Kitchel1 shared
Lu Deng1 shared
Nicole M Li1 shared
Full investigator report
Get the verbatim findings behind Miriam M Ngundi's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site